FDC Ltd, founded in 1936 as one of India's leading integrated pharmaceutical companies and a pioneer in Oral Rehydration Salts (ORS) with
FDC Q2 FY26 Earnings Results
Categories
Pharmaceutical
Entero Healthcare Q2 FY26 Earnings Results
Entero Healthcare Solutions Ltd, incorporated in 2018 and engaged in distribution and marketing of pharmaceutical and surgical products with allied services, reported
Akums Drugs Q2 FY26 Earnings Results
Akums Drugs & Pharmaceuticals Ltd, established in 2004 as India's leading pharmaceutical CDMO offering comprehensive product development and manufacturing services across formulations,
Emcure Q2 FY26 Earnings Results
Emcure Pharmaceuticals Ltd , incorporated in 1981 and a global manufacturer and marketer of pharmaceutical products, reported strong financial results for Q2FY26.
Blue Jet Healthcare Q2 FY26 Earnings Results
Blue Jet Healthcare Ltd, incorporated in 1968 and the first manufacturer of saccharin and its salts (artificial sweeteners) in India, is engaged
Wockhardt Q2 FY26 Earnings Results
Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).
ERIS Lifesciences Q2 FY26 Earnings Results
ERIS Lifesciences Ltd, engaged in the manufacturing and marketing of pharmaceutical products, reported robust financial results for Q2FY26. Financial Highlights: Revenues increased
Alkem Laboratories Q2 FY26 Earnings Results
Alkem Laboratories, engaged in the pharmaceutical and nutraceutical business with global operations, reported steady financial results for Q2FY26. Financial Highlights: Revenues increased
Orchid Pharma Q2 FY26 Earnings Results
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It
Mankind Pharma Q2 FY26 Earnings Results
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer
Zydus LifeSciences Q2 FY26 Earnings Results
In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble
Lupin Q2 FY26 Earnings Results
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,
Piramal Pharma Q2 FY26 Earnings Results
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments: Contract development and
Solara Active Pharma Q2 FY26 Earnings Results
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.
Aurobindo Pharma Q2 FY26 Earnings Results
Aurobindo Pharma Ltd, a leading pharmaceutical company focused on active pharmaceutical ingredients and generic pharmaceuticals, reported a steady Q2FY26 financial performance with
Sun Pharma Q2 FY26 Earnings Results
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations
Ajanta Pharma Q2 FY26 Earnings Results
Ajanta Pharma, specializing in specialty pharmaceutical manufacturing and marketing, reported a solid Q2 FY26 performance. Financial Overview: Revenues increased 14.07% to ₹1,354
RPG Life Sciences Q2 FY26 Earnings Results
Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients. Presenting below are its
AGI Greenpac Q2 FY26 Earnings Results
AGI Greenpac Ltd, incorporated in 1960, is a leading manufacturer of packaging products, including container glass bottles, PET bottles, and security caps
Emcure Q1 FY26 Earnings Results
Company Overview: Incorporated in 1981, Emcure Pharmaceuticals Ltd manufactures and markets pharmaceutical products globally, serving diverse therapeutic segments. Presenting below its Q1
Piramal Pharma Q1 FY26 Earnings Results
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments: (1) Contract development